Prochlorperazine
Discover related
3 sources
🧬 Receptor activity
| Target | Action | Affinity | Source | |
|---|---|---|---|---|
| D(2) dopamine receptor (DRD2) | Antagonist | 8.764 Ki | DRUGCENTRAL | TargetD(2) dopamine receptor (DRD2) ActionAntagonist Affinity8.764 Ki SourceDRUGCENTRAL |
| D(3) dopamine receptor (DRD3) | Antagonist | 8.611 Ki | DRUGCENTRAL | TargetD(3) dopamine receptor (DRD3) ActionAntagonist Affinity8.611 Ki SourceDRUGCENTRAL |
| 5-hydroxytryptamine receptor 1A (HTR1A) | — | 5.229 Ki | DRUGCENTRAL | Target5-hydroxytryptamine receptor 1A (HTR1A) Action— Affinity5.229 Ki SourceDRUGCENTRAL |
| 5-hydroxytryptamine receptor 1B (Htr1b) | — | 5.919 Ki | DRUGCENTRAL | Target5-hydroxytryptamine receptor 1B (Htr1b) Action— Affinity5.919 Ki SourceDRUGCENTRAL |
| 5-hydroxytryptamine receptor 2A (HTR2A) | — | 7.824 Ki | DRUGCENTRAL | Target5-hydroxytryptamine receptor 2A (HTR2A) Action— Affinity7.824 Ki SourceDRUGCENTRAL |
| 5-hydroxytryptamine receptor 2B (HTR2B) | — | 7.187 Ki | DRUGCENTRAL | Target5-hydroxytryptamine receptor 2B (HTR2B) Action— Affinity7.187 Ki SourceDRUGCENTRAL |
| 5-hydroxytryptamine receptor 2C (HTR2C) | — | 6.914 Ki | DRUGCENTRAL | Target5-hydroxytryptamine receptor 2C (HTR2C) Action— Affinity6.914 Ki SourceDRUGCENTRAL |
| 5-hydroxytryptamine receptor 4 (HTR4) | — | 6.712 Ki | DRUGCENTRAL | Target5-hydroxytryptamine receptor 4 (HTR4) Action— Affinity6.712 Ki SourceDRUGCENTRAL |
| 5-hydroxytryptamine receptor 6 (HTR6) | — | 6.907 Ki | DRUGCENTRAL | Target5-hydroxytryptamine receptor 6 (HTR6) Action— Affinity6.907 Ki SourceDRUGCENTRAL |
| Alpha-1A adrenergic receptor (ADRA1A) | — | 7.622 Ki | DRUGCENTRAL | TargetAlpha-1A adrenergic receptor (ADRA1A) Action— Affinity7.622 Ki SourceDRUGCENTRAL |
| Alpha-1B adrenergic receptor (Adra1b) | — | 7.31 Ki | DRUGCENTRAL | TargetAlpha-1B adrenergic receptor (Adra1b) Action— Affinity7.31 Ki SourceDRUGCENTRAL |
| Alpha-1D adrenergic receptor (ADRA1D) | — | 7.886 Ki | DRUGCENTRAL | TargetAlpha-1D adrenergic receptor (ADRA1D) Action— Affinity7.886 Ki SourceDRUGCENTRAL |
| Alpha-2A adrenergic receptor (ADRA2A) | — | 7.201 Ki | DRUGCENTRAL | TargetAlpha-2A adrenergic receptor (ADRA2A) Action— Affinity7.201 Ki SourceDRUGCENTRAL |
| Alpha-2B adrenergic receptor (ADRA2B) | — | 8.324 Ki | DRUGCENTRAL | TargetAlpha-2B adrenergic receptor (ADRA2B) Action— Affinity8.324 Ki SourceDRUGCENTRAL |
| Alpha-2C adrenergic receptor (ADRA2C) | — | 7.921 Ki | DRUGCENTRAL | TargetAlpha-2C adrenergic receptor (ADRA2C) Action— Affinity7.921 Ki SourceDRUGCENTRAL |
| Cytochrome P450 1A2 (CYP1A2) | — | 5.699 IC50 | DRUGCENTRAL | TargetCytochrome P450 1A2 (CYP1A2) Action— Affinity5.699 IC50 SourceDRUGCENTRAL |
| Cytochrome P450 2D6 (CYP2D6) | — | 6.523 IC50 | DRUGCENTRAL | TargetCytochrome P450 2D6 (CYP2D6) Action— Affinity6.523 IC50 SourceDRUGCENTRAL |
| D(1A) dopamine receptor (DRD1) | — | 7.108 Ki | DRUGCENTRAL | TargetD(1A) dopamine receptor (DRD1) Action— Affinity7.108 Ki SourceDRUGCENTRAL |
| D(4) dopamine receptor (DRD4) | — | 7.17 Ki | DRUGCENTRAL | TargetD(4) dopamine receptor (DRD4) Action— Affinity7.17 Ki SourceDRUGCENTRAL |
| Histamine H1 receptor (HRH1) | — | 7.723 Ki | DRUGCENTRAL | TargetHistamine H1 receptor (HRH1) Action— Affinity7.723 Ki SourceDRUGCENTRAL |
| Membrane-associated progesterone receptor component 1 (Pgrmc1) | — | 6.381 Ki | DRUGCENTRAL | TargetMembrane-associated progesterone receptor component 1 (Pgrmc1) Action— Affinity6.381 Ki SourceDRUGCENTRAL |
| Muscarinic acetylcholine receptor M1 (CHRM1) | — | 6.613 Ki | DRUGCENTRAL | TargetMuscarinic acetylcholine receptor M1 (CHRM1) Action— Affinity6.613 Ki SourceDRUGCENTRAL |
| Muscarinic acetylcholine receptor M2 (CHRM2) | — | 5.956 Ki | DRUGCENTRAL | TargetMuscarinic acetylcholine receptor M2 (CHRM2) Action— Affinity5.956 Ki SourceDRUGCENTRAL |
| Muscarinic acetylcholine receptor M3 (CHRM3) | — | 6.493 Ki | DRUGCENTRAL | TargetMuscarinic acetylcholine receptor M3 (CHRM3) Action— Affinity6.493 Ki SourceDRUGCENTRAL |
| Muscarinic acetylcholine receptor M4 (CHRM4) | — | 6.721 Ki | DRUGCENTRAL | TargetMuscarinic acetylcholine receptor M4 (CHRM4) Action— Affinity6.721 Ki SourceDRUGCENTRAL |
| Muscarinic acetylcholine receptor M5 (CHRM5) | — | 6.801 Ki | DRUGCENTRAL | TargetMuscarinic acetylcholine receptor M5 (CHRM5) Action— Affinity6.801 Ki SourceDRUGCENTRAL |
| Pleiotropic ABC efflux transporter of multiple drugs (PDR5) | — | 5.77 IC50 | DRUGCENTRAL | TargetPleiotropic ABC efflux transporter of multiple drugs (PDR5) Action— Affinity5.77 IC50 SourceDRUGCENTRAL |
| Potassium voltage-gated channel subfamily H member 2 (KCNH2) | — | 5.82 Ki | DRUGCENTRAL | TargetPotassium voltage-gated channel subfamily H member 2 (KCNH2) Action— Affinity5.82 Ki SourceDRUGCENTRAL |
| Sigma non-opioid intracellular receptor 1 (SIGMAR1) | — | 7.638 Ki | DRUGCENTRAL | TargetSigma non-opioid intracellular receptor 1 (SIGMAR1) Action— Affinity7.638 Ki SourceDRUGCENTRAL |
| Sodium-dependent dopamine transporter (SLC6A3) | — | 5.86 Ki | DRUGCENTRAL | TargetSodium-dependent dopamine transporter (SLC6A3) Action— Affinity5.86 Ki SourceDRUGCENTRAL |
| Sodium-dependent noradrenaline transporter (SLC6A2) | — | 6.402 Ki | DRUGCENTRAL | TargetSodium-dependent noradrenaline transporter (SLC6A2) Action— Affinity6.402 Ki SourceDRUGCENTRAL |
| Sodium-dependent serotonin transporter (SLC6A4) | — | 6.207 Ki | DRUGCENTRAL | TargetSodium-dependent serotonin transporter (SLC6A4) Action— Affinity6.207 Ki SourceDRUGCENTRAL |
| Solute carrier family 22 member 1 (SLC22A1) | — | 4.3 IC50 | DRUGCENTRAL | TargetSolute carrier family 22 member 1 (SLC22A1) Action— Affinity4.3 IC50 SourceDRUGCENTRAL |
| Tyrosine-protein kinase Fyn (FYN) | — | 5.245 IC50 | DRUGCENTRAL | TargetTyrosine-protein kinase Fyn (FYN) Action— Affinity5.245 IC50 SourceDRUGCENTRAL |
External links
PubChem 4917 ↗CAS 58-38-8 ↗KEGG C07403 ↗KEGG C16030 ↗ChEBI CHEBI:8435 ↗ChEMBL CHEMBL728 ↗KEGG D00493 ↗DrugBank DB00433 ↗NIH ↗ChemSpider ↗ChEBI/ChEMBL ↗ChEBI/ChEMBL ↗Guide to Pharmacology ↗NIH ↗NIH ↗NIH ↗DrugBank ↗ChEBI/ChEMBL ↗NIH ↗CAS 1215641-01-2 ↗CAS 51888-09-6 ↗PsychonautWiki ↗Erowid ↗Experience reports (PiHKAL) ↗Experience reports (TiHKAL) ↗
Source: DrugCentral — Prochlorperazine ↗
Fact-sheets from PsychonautWiki. Harm-reduction reference only — not medical advice.